A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

NCT00001436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Neoplasm Metastasis
Osteosarcoma

Interventions

DRUG: OncoLAR® (Registered Trademark)
DRUG: tamoxifen

Sponsor

National Cancer Institute (NCI)